.ANALYSIS FEATURE.06 August 2024.
A sizable randomized controlled trial with cisgender ladies highlights the problems of faithfulness to a day-to-day dental preexposure prophylaxis regiment and also illustrates that twice-yearly injection of lenacapavir can keep reliable HIV protection amounts over 6 months.